ATE291034T1 - Herstellungsverfahren einer virusfreien faktor viii-lösung durch filtration - Google Patents

Herstellungsverfahren einer virusfreien faktor viii-lösung durch filtration

Info

Publication number
ATE291034T1
ATE291034T1 AT98959975T AT98959975T ATE291034T1 AT E291034 T1 ATE291034 T1 AT E291034T1 AT 98959975 T AT98959975 T AT 98959975T AT 98959975 T AT98959975 T AT 98959975T AT E291034 T1 ATE291034 T1 AT E291034T1
Authority
AT
Austria
Prior art keywords
factor viii
virus
filtration
production
solution
Prior art date
Application number
AT98959975T
Other languages
English (en)
Inventor
Abdessatar Chtourou
Michel Nogre
Pierre Porte
Original Assignee
Lab Francais Du Fractionnement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9514631&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE291034(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lab Francais Du Fractionnement filed Critical Lab Francais Du Fractionnement
Application granted granted Critical
Publication of ATE291034T1 publication Critical patent/ATE291034T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98959975T 1997-12-15 1998-12-14 Herstellungsverfahren einer virusfreien faktor viii-lösung durch filtration ATE291034T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9715888A FR2772381B1 (fr) 1997-12-15 1997-12-15 Procede de preparation par filtration d'une solution de facteur viii securisee viralement
PCT/FR1998/002715 WO1999031138A1 (fr) 1997-12-15 1998-12-14 Procede de preparation par filtration d'une solution de facteur viii securisee viralement

Publications (1)

Publication Number Publication Date
ATE291034T1 true ATE291034T1 (de) 2005-04-15

Family

ID=9514631

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98959975T ATE291034T1 (de) 1997-12-15 1998-12-14 Herstellungsverfahren einer virusfreien faktor viii-lösung durch filtration

Country Status (11)

Country Link
US (1) US6967239B1 (de)
EP (1) EP1037923B2 (de)
JP (1) JP4312381B2 (de)
AT (1) ATE291034T1 (de)
AU (1) AU752271B2 (de)
CA (1) CA2314610C (de)
DE (1) DE69829408T3 (de)
ES (1) ES2237854T5 (de)
FR (1) FR2772381B1 (de)
PT (1) PT1037923E (de)
WO (1) WO1999031138A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU784808B2 (en) * 2001-04-02 2006-06-29 Kedrion Melville Inc. Prion and viral clearance process
DE10211632A1 (de) * 2002-03-15 2003-10-09 Aventis Behring Gmbh Verfahren zur Abtrennung von Viren aus einer Proteinlösung durch Nanofiltration
ES2214967B1 (es) * 2003-03-06 2005-06-16 Probitas Pharma, S.A Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento.
FR2861395B1 (fr) * 2003-10-23 2006-02-17 Lab Francais Du Fractionnement Facteur viii viralement securise a faible teneur en multimeres superieurs
FR2920429B1 (fr) * 2007-08-30 2012-10-05 Lfb Biotechnologies Procede de purification du facteur viii et du facteur von willebrand
TW201731488A (zh) 2007-12-28 2017-09-16 巴克斯歐塔公司 重組ｖｗｆ調配物
CA2709781C (en) 2007-12-28 2017-03-14 Baxter International Inc. Counter-pressure filtration of proteins
ES2298096B1 (es) 2008-01-08 2009-01-01 Grifols, S.A. Procedimiento para la obtencion de un concentrado de factor von willebrand o del complejo de factor viii/factor von willebrand y utilizacionde los mismos.
TWI469992B (zh) * 2008-08-28 2015-01-21 Baxter Int 濃縮剪切靈敏生物聚合物的方法
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
US20140154233A1 (en) 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
AU2018321131B2 (en) * 2017-08-23 2024-06-13 Csl Behring Gmbh Method for virus filtration of von Willebrand Factor
CA3091348A1 (en) * 2018-02-19 2019-08-22 Bayer Healthcare Llc Modified filter membrane and method

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673733A (en) * 1985-04-11 1987-06-16 Sudhish Chandra Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents
US4758657A (en) † 1985-07-11 1988-07-19 Armour Pharmaceutical Company Method of purifying Factor VIII:C
FR2644064B1 (fr) * 1989-02-17 1994-05-27 Aquitaine Dev Transf Sanguine Procede de fabrication du facteur antihemophilique fviiic ayant une tres haute purete et facteur antihemophilique fviiic ainsi obtenu, ainsi que composition pharmaceutique le contenant
FR2662166A1 (fr) * 1990-05-18 1991-11-22 Fondation Nale Transfusion San Procede de preparation de facteur viii de tres haute purete comprenant une etape rapide d'immunoadsorption.
IT1248723B (it) * 1990-06-12 1995-01-26 Scalvo S P A Processo per la purificazione del fattore viii e fattore viii ottenuto con tale processo
FR2681867B1 (fr) * 1991-09-26 1993-12-31 Pasteur Merieux Serums Vaccins Procede de purification du facteur viii et preparations obtenues.
SE9500724D0 (sv) * 1994-06-23 1995-02-24 Pharmacia Ab Filtrering
DE4435392B4 (de) 1994-10-04 2008-02-07 Immuno Ag Verfahren zur Trennung von vWF in hochmolekularen vWF und niedermolekularen vWF
US5677162A (en) * 1995-05-01 1997-10-14 New York Blood Center, Inc. Method for activating prothrombin to thrombin
EP0860444A1 (de) * 1997-02-24 1998-08-26 Stichting Centraal Laboratorium van de Bloedtransfusiedienst van het Nederlandse Rode Kruis (CLB) Methode zur Entfernung von Viren aus Proteinlösungen

Also Published As

Publication number Publication date
EP1037923B2 (de) 2015-09-09
ES2237854T3 (es) 2005-08-01
WO1999031138A1 (fr) 1999-06-24
FR2772381A1 (fr) 1999-06-18
FR2772381B1 (fr) 2001-06-08
CA2314610A1 (fr) 1999-06-24
CA2314610C (fr) 2012-06-19
DE69829408D1 (de) 2005-04-21
ES2237854T5 (es) 2015-10-05
DE69829408T3 (de) 2015-11-12
EP1037923A1 (de) 2000-09-27
PT1037923E (pt) 2005-06-30
JP2002508396A (ja) 2002-03-19
DE69829408T8 (de) 2006-08-10
JP4312381B2 (ja) 2009-08-12
US6967239B1 (en) 2005-11-22
AU1568199A (en) 1999-07-05
DE69829408T2 (de) 2006-04-13
EP1037923B9 (de) 2006-08-23
AU752271B2 (en) 2002-09-12
EP1037923B1 (de) 2005-03-16

Similar Documents

Publication Publication Date Title
ATE291034T1 (de) Herstellungsverfahren einer virusfreien faktor viii-lösung durch filtration
DE69427636D1 (de) Verfahren zur Herstellung von hermetisch abgedichteten Filtereinheiten
DE69111115D1 (de) Verfahren zur Herstellung poröser Keramikfilter unter Verwendung von Talk- und SiO2-Pulver enthaltendem Cordierit.
DE69333430D1 (de) Filter, Methoden zur Herstellung eines Filters und Filtermethoden
DE69305905D1 (de) Verfahren zur Herstellung von Vanadium enthaltenden elektrolytischen Lösungen
DE69525422D1 (de) Verfahren zur Herstellung von hochreiner Vanadium-Elektrolytlösung
DE69104461D1 (de) Verfahren zur Erzeugung von hochreinem Wasserstoff.
DE59506573D1 (de) Verfahren zur Herstellung von Filtern
DE59308090D1 (de) Verfahren zur Ueberwachung von Filterelemente
DE69003009D1 (de) Verfahren zur Behandlung von Fasermaterialien.
DE69116828D1 (de) Verfahren zur Herstellung von Zellstoff
ATE236659T1 (de) Entfernen von viren durch ultrafiltration aus proteinlösungen
DE68922327D1 (de) Verfahren zur Herstellung von Vliesstoffen aus Kohlenstoffasern.
ATE196153T1 (de) Verfahren zur reinigung von faktor viii-von willebrand faktor (fviii:c-fvw) komplex aus menschlichem plasma
AU747417C (en) Filtration method for separating viruses
ATA344084A (de) Waschfilter zur aufbereitung von faserstoffsuspensionen
FI952196A0 (fi) Framstaellning av immunoglobulin
DE69032578D1 (de) Verfahren zur herstellung und reinigung von einer glykosphingolipidmischung frei von verunreinigungen durch ungewöhnliche viren
DE59106273D1 (de) Verfahren zur abreicherung von viren in lösungen und zur bestimmung der abreicherungsrate von viren.
DE69112584D1 (de) Sol-Gel-Verfahren zur Herstellung von keramischen Materialen.
ATA135687A (de) Verfahren zur herstellung von neuen 1,4-dihydropyridinen
ATA721279A (de) Verfahren zur herstellung von neuen p-oxybenzoyl- copolyestern, und ihre loesungen
DE69123306D1 (de) Verfahren zur Herstellung von Farbfiltern
DE69008424D1 (de) Verfahren zur Erzeugung von Nitrobenzolen.
BR8702045A (pt) Aparelho de filtro e processo de filtragem

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1037923

Country of ref document: EP